Pluripotent stem cell-engineered cell sheets reassembled with defined cardiovascular populations ameliorate reduction in infarct heart function through cardiomyocyte-mediated neovascularization

Stem Cells

Volumn 30, Issue 6, 2012, Pages 1196-1205

  Masumoto, Hidetoshi ^a,b,c   Matsuo, Takehiko ^a,b,c   Yamamizu, Kohei ^a,b   Uosaki, Hideki ^a,b   Narazaki, Genta ^a,b   Katayama, Shiori ^a,b   Marui, Akira ^c,d   Shimizu, Tatsuya ^e   Ikeda, Tadashi ^c   Okano, Teruo ^e   Sakata, Ryuzo ^c   Yamashita, Jun K ^a,b  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d KYOTO UNIVERSITY HOSPITAL   (Japan)

^e TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Myocardial infarction; Pluripotent stem cells; Tissue engineering; Ventricular remodeling

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ENGINEERING; CELL TRANSPLANTATION; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; MALE; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PROSPECTIVE STUDY; RAT;

ANIMALS; CORONARY VESSELS; DISEASE MODELS, ANIMAL; MALE; MICE; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC; PLURIPOTENT STEM CELLS; PROSPECTIVE STUDIES; RATS; RATS, NUDE; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

RATTUS;

EID: 84861873989     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1089     Document Type: Article

References (62)

1. Orlic D, Kajstura J, Chimenti S et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701-705. (Pubitemid 32290358)
2. Tomita S, Li RK, Weisel RD et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 1999;100:II247-II256. (Pubitemid 29523543)
3. Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-967. (Pubitemid 27087709)
4. Murry CE, Wiseman RW, Schwartz SM et al. Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest 1996;98:2512-2523. (Pubitemid 26415072)
5. Messina E, De Angelis L, Frati G et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 2004;95:911-921. (Pubitemid 39435006)
6. Matsuura K, Honda A, Nagai T et al. Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. J Clin Invest 2009;119:2204-2217.
7. Kolossov E, Bostani T, Roell W et al. Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med 2006;203:2315-2327. (Pubitemid 44498366)
8. Chien KR. Regenerative medicine and human models of human disease. Nature 2008;453:302-305. (Pubitemid 351693135)
9. Assmus B, Rolf A, Erbs S et al. Clinical outcome 2 years after intra-coronary administration of bone marrow-derived progenitor cells in acute myocardial infarction. Circ Heart Fail 2010;3:89-96.
10. Hirsch A, Nijveldt R, van der Vleuten PA et al. Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: Results of the randomized controlled HEBE trial. Eur Heart J 2011;32:1736-1747.
11. Huikuri HV, Kervinen K, Niemel€a M et al. Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. Eur Heart J 2008;29:2723-2732.
12. Assmus B, Fischer-Rasokat U, Honold J et al. Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: Results of the TOPCARE-CHD Registry. Circ Res 2007;100:1234-1241. (Pubitemid 46684137)
13. Tendera M, Wojakowski W, Ruzy[swsl]l[swsl]lo W et al. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: Results of randomized, multicentre myocardial regeneration by intracoronary infusion of selected population of stem cells in acute myocardial infarction (REGENT) Trial. Eur Heart J 2009;30:1313-1321.
14. Losordo DW, Schatz RA, White CJ et al. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: A phase I/IIa double-blind, randomized controlled trial. Circulation 2007;115:3165-3172. (Pubitemid 47018140)
15. Menasché P, Alfieri O, Janssens S et al. The myoblast autologous grafting in ischemic cardiomyopathy (MAGIC) trial: First randomized placebo-controlled study of myoblast transplantation. Circulation 2008;117:1189-1200. (Pubitemid 351552018)
16. Dib N, Dinsmore J, Lababidi Z et al. One-year follow-up of feasibility and safety of the first U.S., randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study). JACC Cardiovasc Interv 2009;2:9-16.
17. Takehara N, Tsutsumi Y, Tateishi K et al. Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction. J Am Coll Cardiol 2008;52:1858-1865.
18. Li TS, Cheng K, Malliaras K et al. Expansion of human cardiac stem cells in physiological oxygen improves cell production efficiency and potency for myocardial repair. Cardiovasc Res 2011;89:157-165.
19. Menasché P. Cardiac cell therapy: Lessons from clinical trials. J Mol Cell Cardiol 2011;50:258-265.
20. Wollert KC, Drexler H. Cell therapy for the treatment of coronary heart disease: A critical appraisal. Nat Rev Cardiol 2010;7:204-215.
21. Zimmermann WH, Melnychenko I, Wasmeier G et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 2006;12:452-458.
22. Psaltis PJ, Zannettino ACW, Worthley SG et al. Concise review: Mesenchymal stromal cells: Potential for cardiovascular repair. Stem Cells 2008;26:2201-2210.
23. Tang XL, Rokosh G, Sanganalmath SK et al. Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation 2010;121:293-305.
24. Cho HJ, Lee N, Lee JY et al. Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart. J Exp Med 2007;204:3257-3269.
25. Kocher AA, Schuster MD, Szabolcs MJ et al. Neovascularization of ischemic myocardium by human bone-marrow derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001;7:430-436. (Pubitemid 32298545)
26. Mirotsou M, Jayawardena TM, Schmeckpeper J et al. Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. J Mol Cell Cardiol 2011;50:280-289.
27. Joggerst SJ, Hatzopoulos AK. Stem cell therapy for cardiac repair: Benefits and barriers. Expert Rev Mol Med 2009;11:e20.
28. Yamashita J, Itoh H, Hirashima M et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 2000;408:92-96.
29. Yamamizu K, Kawasaki K, Katayama S et al. Enhancement of vascular progenitor potential by protein kinase A through dual induction of Flk-1 and Neuropilin-1. Blood 2009;114:3707-3716.
30. Yamashita JK, Takano M, Hiraoka-Kanie M et al. Prospective identification of cardiac progenitors by a novel single cell-based cardiomyocyte induction. FASEB J 2005;19:1534-1536. (Pubitemid 41279022)
31. Narazaki G, Uosaki H, Teranishi M et al. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 2008;118:498-506.
32. Pelacho B, Mazo M, Gavira JJ et al. Adult stem cells: From new cell sources to changes in methodology. J Cardiovasc Transl Res 2011;4:154-160.
33. Okano T, Yamada N, Sakai H et al. A novel recovery system for cultured cells using plasma-treated polystyrene dishes grafted with poly (N-isopropylacrylamide). J Biomed Mater Res 1993;27:1243-1251. (Pubitemid 23289647)
34. Bel A, Planat-Bernard V, Saito A et al. Composite cell sheets: A further step toward safe and effective myocardial regeneration by cardiac progenitors derived from embryonic stem cells. Circulation 2010;122:S118-S123.
35. Sekine H, Shimizu T, Hobo K et al. Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts. Circulation 2008;118:S145-S152.
36. Miyahara Y, Nagaya N, Kataoka M et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 2006;12:459-465.
37. Yan P, Nagasawa A, Uosaki H et al. Cyclosporin-A potently induces highly cardiogenic progenitors from embryonic stem cells. Biochem Biophys Res Commun 2009;379:115-120.
38. Yurugi-Kobayashi T, Itoh H, Schroeder T et al. Adrenomedullin/cyclic AMP pathway induces Notch activation and differentiation of arterial endothelial cells from vascular progenitors. Arterioscler Thromb Vasc Biol 2006;26:1977-1984. (Pubitemid 44253777)
39. Nishina T, Nishimura K, Yuasa S et al. Initial effects of the left ventricular repair by plication may not last long in a rat ischemic cardiomyopathy model. Circulation 2001;104:I241-I245.
40. Sakakibara Y, Tambara K, Lu F et al. Combined procedure of surgical repair and cell transplantation for left ventricular aneurysm: An experimental study. Circulation 2002;106:I193-I197.
41. Pacher P, Nagayama T, Mukhopadhyay P et al. Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat Protoc 2008;3:1422-1434.
42. Nishiyama N, Miyoshi S, Hida N et al. The significant cardiomyogenic potential of human umbilical cord blood-derived mesenchymal stem cells in vitro. Stem Cells 2007;25:2017-2024. (Pubitemid 47258179)
43. Young DM, Greulich KM, Weier HG. Species-specific in situ hybridization with fluorochrome-labeled DNA probes to study vascularization of human skin grafts on athymic mice. J Burn Care Rehabil 1996;17:305-310. (Pubitemid 26286639)
44. Ieda M, Tsuchihashi T, Ivey KN et al. Cardiac fibroblasts regulate myocardial proliferation through b1 integrin signaling. Dev Cell 2009;16:233-244.
45. Miragoli M, Gaudesius G, Rohr S. Electrotonic modulation of cardiac impulse conduction by myofibroblasts. Circ Res 2006;98:801-810.
46. Olivetti G, Capasso JM, Meggs LG et al. Cellular basis of chronic ventricular remodeling after myocardial infarction in rats. Circ Res 1991;68:856-869.
47. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990;81:1161-1172. (Pubitemid 20119612)
48. Braunwald E. Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded? Circulation 1989;79:441-444. (Pubitemid 19055515)
49. Yoon CH, Koyanagi M, Iekushi K et al. Mechanism of improved cardiac function after bone marrow mononuclear cell therapy: Role of cardiovascular lineage commitment. Circulation 2010;121:2001-2011.
50. Dufourcq P, Leroux L, Ezan J et al. Regulation of endothelial cell cytoskeletal reorganization by a secreted frizzled-related protein-1 and Frizzled 4- and Frizzled 7-dependent pathway: Role in neovessel formation. Am J Pathol 2008;172:37-49. (Pubitemid 351186366)
51. Bock-Marquette I, Saxena A, White MD et al. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 2004;432:466-472. (Pubitemid 39576522)
52. Smart N, Bollini S, Dubé KN et al. De novo cardiomyocytes from within the activated adult heart after injury. Nature 2011;474:640-644.
53. Hornebeck W. Down-regulation of tissue inhibitor of matrix metalloprotease-1 (TIMP-1) in aged human skin contributes to matrix degradation and impaired cell growth and survival. Pathol Biol 2003;51:569-573. (Pubitemid 37466375)
54. Ikonomidis JS, Hendrick JW, Parkhurst AM et al. Accelerated LV remodeling after myocardial infarction in TIMP-1-deficient mice: Effects of exogenous MMP inhibition. Am J Physiol Heart Circ Physiol 2005;288:H149-H158. (Pubitemid 40023842)
55. Li RK, Mickle DAG, Weisel RD et al. Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury. Ann Thorac Surg 2001;72:1957-1963. (Pubitemid 34001449)
56. Sumitra M, Manikandan P, Nayeem M et al. Time course studies on the initiation of complement activation in acute myocardial infarction induced by coronary artery ligations in rats. Mol Cell Biochem 2005;268:149-158. (Pubitemid 40287837)
57. Mashimo T, Takizawa A, Voigt B et at. Generation of knockout rats with X-linked severe combined immunodeficiency (X-SCID) using zinc-finger nucleases. PLoS One 2010;5:e8870.
58. Sekiya S, Muraoka M, Sasagawa T et al. Three-dimensional cell-dense constructs containing endothelial cell-networks are an effective tool for in vivo and in vitro vascular biology research. Microvasc Res 2010;80:549-551.
59. Stevens KR, Kreutziger KL, Dupras SK et al. Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue. Proc Natl Acad Sci USA 2009;106:16568-16573.
60. Fujiwara M, Yan P, Otsuji TG et al. Induction and enhancement of cardiac cell differentiation from mouse and human induced pluripotent stem cells with cyclosporin-A. PLoS One 2011;6:e16734.
61. Uosaki H, Fukushima H, Takeuchi A et al. Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression. PLoS One 2011;6:e23657.
62. Taura D, Sone M, Homma K et al. Induction and isolation of vascular cells from human induced pluripotent stem cells - Brief report. Arterioscler Thromb Vasc Biol 2009;29:1100-1103.